- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- Patient Resources
Recent policymaking and an increased awareness around patient-centric care are resulting in a renewed interest in home-dialysis as a treatment option for kidney failure. Peritoneal dialysis is a great option to facilitate the freedom of home renal replacement therapy. Despite the long-history of this treatment modality as a viable option for many patients, its use remains relatively low in comparison to in-center hemodialysis. Join us for this informative webinar as renowned home dialysis experts Dr Ankur Shah and Dr Natasha Dave review and counter common perceived barriers to utilizing peritoneal dialysis in various populations.
*Drs Natasha Dave and Ankur Shah are paid consultants of Otsuka Pharmaceutical & Commercialization, Inc. (OPDC). Dr Aaron Emmel is an employee of OPDC.
Natasha N Dave, MD is a nephrologist and medical director at Strive Health in Florida. She completed her internal medicine residency training at Mount Sinai Hospital in Chicago and then completed her Nephrology fellowship and chief year at Baylor in Houston. Post-fellowship she joined Baylor as an assistant professor of medicine primarily practicing at the Michael E DeBakey VA Medical Center prior to moving to Miami. While in Houston, her predominant interest included a quality improvement (QI) project assessing the impact of a monthly telehealth clinic for rural chronic kidney disease patients.
Dr Dave’s other clinical and educational interests include mentorship, social media/educational content generation, and as her Twitter profile (@NatashaNDave) suggests, electrolytes. She serves on the Executive Council of Women in Nephrology and is involved in a number of online projects and roles that began after she completed a one year social media internship with the Nephrology Social Media Collective (NSMC). Some of these roles include being a faculty contributor for the Renal Fellow Network and American Journal of Kidney Diseases blogs as well as partaking in social media activities with National Kidney Foundation, Nephrology Business Leadership University, Kidney Medicine, and NSMC.
Warren Alpert Medical School, Brown University*
Ankur Shah, MD is an Assistant Professor of Medicine at the Warren Alpert Medical School of Brown University, where he is the associate program director of the nephrology fellowship. He completed residency in internal medicine at Temple University Hospital, followed by fellowship at the Hospital of the University of Pennsylvania, where he served as chief fellow and received advanced training in medical education. He is a Fellow of the American Society of Nephrology and the National Kidney Foundation. Dr Shah is a graduate of the Nephrology Social Media Collective internship as well as a current American Society of Nephrology Public Policy Intern and Renal Physicians Association Public Policy Fellow. His primary interests are peritoneal dialysis, home hemodialysis, and medical education.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Aaron Emmel, PharmD, MHA, BCPS, joined Otsuka in 2018 and is currently a Senior Medical Science Liaison on our Nephrology South Team. Dr Emmel earned his Doctor in Pharmacy from the University of Florida in 2007 and his Masters in Health Administration from the University of North Florida in 2015. He has 10 years of experience as a clinical pharmacist, helping to develop and implement numerous clinical programs focused on ICU care, nutrition support, and antimicrobial stewardship. Additionally, he served as an administrator for a multi-specialty Clinically Integrated Network and ACO, helping to develop a Population Health Management strategy that included a coordinated approach to managing Chronic Kidney Disease. He has served as an Associate Clinical Professor for the University of Florida College of Pharmacy, delivering lectures and precepting students on Advanced Pharmacy Practice Experience rotations. Dr Emmel is Board Certified as a Pharmacotherapy Specialist by the Board of Pharmacy Specialties.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
February 14 from 12:00 pm to 1:00 pm
- Resource Center
- Patient Resources